Using Mutagenesis and Structural Biology to Map the Binding Site for thePlasmodium falciparumMerozoite Protein PfRh4 on the Human Immune Adherence Receptor
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using Mutagenesis and Structural Biology to Map the Binding Site for thePlasmodium falciparumMerozoite Protein PfRh4 on the Human Immune Adherence Receptor
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 1, Pages 450-463
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-11-09
DOI
10.1074/jbc.m113.520346
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
- (2013) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Solution Structure of CCP Modules 10–12 Illuminates Functional Architecture of the Complement Regulator, Factor H
- (2012) Elisavet Makou et al. JOURNAL OF MOLECULAR BIOLOGY
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Lack of Evidence from Studies of Soluble Protein Fragments that Knops Blood Group Polymorphisms in Complement Receptor-Type 1 Are Driven by Malaria
- (2012) Patience B. Tetteh-Quarcoo et al. PLoS One
- Effects of Natural Selection and Gene Conversion on the Evolution of Human Glycophorins Coding for MNS Blood Polymorphisms in Malaria-Endemic African Populations
- (2011) Wen-Ya Ko et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes
- (2011) W.-H. Tham et al. BLOOD
- Super-Resolution Dissection of Coordinated Events during Malaria Parasite Invasion of the Human Erythrocyte
- (2011) David T. Riglar et al. Cell Host & Microbe
- Population Genetics of GYPB and Association Study between GYPB*S/s Polymorphism and Susceptibility to P. falciparum Infection in the Brazilian Amazon
- (2011) Eduardo Tarazona-Santos et al. PLoS One
- Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum
- (2011) Wai-Hong Tham et al. TRENDS IN PARASITOLOGY
- A Research Agenda to Underpin Malaria Eradication
- (2011) Pedro L. Alonso et al. PLOS MEDICINE
- Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand
- (2010) W.-H. Tham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement Receptor 1 Is a Sialic Acid-Independent Erythrocyte Receptor of Plasmodium falciparum
- (2010) Carmenza Spadafora et al. PLoS Pathogens
- Reticulocyte binding protein homologues are key adhesins during erythrocyte invasion byPlasmodium falciparum
- (2009) Tony Triglia et al. CELLULAR MICROBIOLOGY
- Antibodies to Reticulocyte Binding Protein-Like Homologue 4 Inhibit Invasion of Plasmodium falciparum into Human Erythrocytes
- (2009) W.-H. Tham et al. INFECTION AND IMMUNITY
- The Central Portion of Factor H (Modules 10–15) Is Compact and Contains a Structurally Deviant CCP Module
- (2009) Christoph Q. Schmidt et al. JOURNAL OF MOLECULAR BIOLOGY
- Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1
- (2009) D. C. G. Mayer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites
- (2008) Paul R. Gilson et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations
- (2008) Henry G. Hocking et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complement Receptor 1: Disease associations and therapeutic implications
- (2008) Rohan Khera et al. MOLECULAR IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started